Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: Kinetics, molecular modeling, toxicity and effect on growth


Autoria(s): MASCARELLO, Alessandra; CHIARADIA, Louise Domeneghini; VERNAL, Javier; VILLARINO, Andrea; GUIDO, Rafael Victório Carvalho; PERIZZOLO, Paulo; POIRIER, Valerie; WONG, Dennis; MARTINS, Priscila Graziela Alves; NUNES, Ricardo Jose; YUNES, Rosendo Augusto; ANDRICOPULO, Adriano Defini; AV-GAY, Yossef; TERENZI, Hernan
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Tuberculosis (TB) is a major cause of morbidity and mortality throughout the world, and it is estimated that one-third of the world`s population is infected with Mycobacterium tuberculosis. Among a series of tested compounds, we have recently identified five synthetic chalcones which inhibit the activity of M. tuberculosis protein tyrosine phosphatase A (PtpA), an enzyme associated with M. tuberculosis infectivity. Kinetic studies demonstrated that these compounds are reversible competitive inhibitors. In this work we also carried out the analysis of the molecular recognition of these inhibitors on their macromolecular target, PtpA, through molecular modeling. We observed that the predominant determinants responsible for the inhibitory activity of the chalcones are the positions of the two methoxyl groups at the A-ring, that establish hydrogen bonds with the amino acid residues Arg17, His49, and Thr12 in the active site of PtpA, and the substitution of the phenyl ring for a 2-naphthyl group as B-ring, that undergoes p stacking hydrophobic interaction with the Trp48 residue from PtpA. Interestingly, reduction of mycobacterial survival in human macrophages upon inhibitor treatment suggests their potential use as novel therapeutics. The biological activity, synthetic versatility, and low cost are clear advantages of this new class of potential tuberculostatic agents. (C) 2010 Elsevier Ltd. All rights reserved.

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

CNPq

CAPES

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC)

FAPESC

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

FAPESP

MCT

Ministério da Ciência, Tecnologia e Inovação do Brasil (MCTI)

Financiadora de Estudos e Projetos (FINEP)

FINEP

Identificador

BIOORGANIC & MEDICINAL CHEMISTRY, v.18, n.11, p.3783-3789, 2010

0968-0896

http://producao.usp.br/handle/BDPI/30130

10.1016/j.bmc.2010.04.051

http://dx.doi.org/10.1016/j.bmc.2010.04.051

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Bioorganic & Medicinal Chemistry

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #Tuberculosis #Tyrosine phosphatase inhibitors #Chalcones #NATURAL-PRODUCT STRUCTURE #DISCOVERY #PROTEINS #BIOLOGY #MPTPA #SITE #Biochemistry & Molecular Biology #Chemistry, Medicinal #Chemistry, Organic
Tipo

article

original article

publishedVersion